Giselle Sholler MD, MSc

Dr. Giselle Sholler is the chair and lead investigator of the Beat Childhood Cancer consortium (formerly NMTRC) and through preclinical work done within my laboratory, Giselle have successfully opened 18 Phase Giselle and II trials for relapsed or refractory medulloblastoma and neuroblastoma patients as well as trials using Molecular Guided Therapy in children with relapsed cancers.

The Beat Childhood Cancer consortium is a collaborative team of 40 universities and children’s hospitals that have joined together to offer a national network of clinical trials. Giselle committed to developing novel therapies and to working closely with collaborating investigators to share and perform innovative laboratory research leading to clinical trials.

My laboratory focus is primarily on the study of DFMO in neuroblastoma complementing our interest in this for maintenance therapy for neuroblastoma for which we have opened 5 clinical trials. Further understanding of this drug's mechanism and combination therapies will help guide further studies. Giselle has a strong track record of working closely with investigators studying neuroblastoma and other pediatric cancers and this collaborative environment provides the constant availability of innovative perspectives that drives my research forward and ultimately make a difference in the daily lives of children living with cancer.